2hb3: Difference between revisions

Line 20:

==About this Structure==

2HB3 is a ~~[[Single protein]]~~ structure of ~~sequence~~ from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HB3 OCA].

2HB3 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HB3 OCA].

==Reference==

Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance., Ghosh AK, Sridhar PR, Leshchenko S, Hussain AK, Li J, Kovalevsky AY, Walters DE, Wedekind JE, Grum-Tokars V, Das D, Koh Y, Maeda K, Gatanaga H, Weber IT, Mitsuya H, J Med Chem. 2006 Aug 24;49(17):5252-61. PMID:~~[http:~~//~~www.ncbi.nlm.nih.gov/pubmed/16913714 16913714]~~

[[Category: Chymosin]]

[[Category: Human immunodeficiency virus 1]]

~~[[Category: Single protein]]~~

[[Category: Kovalevsky, A Y.]]

[[Category: Weber, I T.]]

[[Category: Active-site cavity protease inhibitor catalytic aspartic acid]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Sun Jul 27 17~~:20:~~28 2008~~''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 14:39:07 2009''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 20: / Line 20: @@
 ==About this Structure==
-HB3 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HB3 OCA].
+HB3 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HB3 OCA].
 ==Reference==
-Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance., Ghosh AK, Sridhar PR, Leshchenko S, Hussain AK, Li J, Kovalevsky AY, Walters DE, Wedekind JE, Grum-Tokars V, Das D, Koh Y, Maeda K, Gatanaga H, Weber IT, Mitsuya H, J Med Chem. 2006 Aug 24;49(17):5252-61. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16913714 16913714]
+<ref group="xtra">PMID:16913714</ref><references group="xtra"/>
 [[Category: Chymosin]]
 [[Category: Human immunodeficiency virus 1]]
-[[Category: Single protein]]
 [[Category: Kovalevsky, A Y.]]
 [[Category: Weber, I T.]]
 [[Category: Active-site cavity protease inhibitor catalytic aspartic acid]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 17:20:28 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 14:39:07 2009''